Program notes:

0:53 Who needs a beta blocker after MI

1:53 Those with mild reduction of ejection fraction

2:53 Confined to those with 40-50% ejection fraction

3:15 Revascularization in NSTEMI

4:20 Composite outcome

5:20 Closes gap, do FFR

6:20 May not be physiologically significant

6:40 Is lifelong anticoagulation needed after ablation

7:41 Occurred less in those who stopped

8:30 RSV, cardiac events and hospitalizations

9:30 Lower hospitalization in those who got the vaccine

10:30 Acute respiratory illness hospitalization

11:30 Less benefit with existing CVD or immunocompromise

12:15 Several RSV vaccines

13:16 End